Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients

Cytometry Part B - Clinical Cytometry

Volumn 88, Issue 3, 2015, Pages 154-164

  Kern, Wolfgang ^a   Bacher, Ulrike ^a   Haferlach, Claudia ^a   Alpermann, Tamara ^a   Schnittger, Susanne ^a   Haferlach, Torsten ^a  

^a MLL MUNICH LEUKEMIA LABORATORY   (Germany)

Author keywords

Diagnosis; Multiparameter flow cytometry; Myelodysplastic syndromes; Prognosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL STRUCTURE; CHILD; CHROMOSOME 7; CHROMOSOME ABERRATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; CYTOPENIA; DIFFERENTIAL DIAGNOSIS; ERYTHROPOIESIS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GRANULOCYTE; GRANULOPOIESIS; HIGH RISK POPULATION; HUMAN; INFANT; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MEGAKARYOPOIESIS; MIXED MYELODYSPLASTIC MYELOPROLIFERATIVE DISEASE; MULTIPARAMETER FLOW CYTOMETRY; MYELODYSPLASTIC SYNDROME; MYELOID PROGENITOR CELL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA AND RINGED SIDEROBLASTS; CHROMOSOME ANALYSIS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; MIDDLE AGED; MORTALITY; MYELODYSPLASTIC SYNDROMES; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; SURVIVAL; VERY ELDERLY;

TUMOR ANTIGEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CHILD; CHILD, PRESCHOOL; CYTOGENETIC ANALYSIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; INFANT; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84928354682     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.21224     Document Type: Article

References (17)

1. Brunning R, Orazi A, Germing U, Le Beau M, Porwit A, Baumann I, Vardiman JW, Hellström-Lindberg E,. Myelodysplastic syndromes. In:, Swerdlow S, H, Campo E, Harris N, L, Jaffe E, S, Pileri S, A, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon: IARC Press; 2008. pp. 87-93.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C., Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
3. Goasguen JE, Matsuo T, Cox C, Bennett JM., Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: Major importance of dysgranulopoiesis for remission and survival. Leukemia 1992; 6: 520-525.
4. Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, Haferlach T, Haase D, Kolb HJ, Krieger O, et al.,. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res 2007; 31: 727-736.
5. Kern W, Haferlach C, Schnittger S, Haferlach T., Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: Correlation to cytomorphology, cytogenetics, and clinical data. Cancer 2010; 116: 4549-4563.
6. Westers TM, Ireland R, Kern W, Alhan C, Balleisen JS, Bettelheim P, Burbury K, Cullen M, Cutler JA, la Porta MG, et al.,. Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European leukemianet working group. Leukemia 2012; 26: 1730-1741.
7. Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM, Deeg HJ., Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003; 102: 394-403.
8. van de Loosdrecht AA, Westers TM, Westra AH, Dräger AM, van der Velden VHJ, Ossenkoppele GJ., Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. Blood 2008; 111: 1067-1077.
9. van de Loosdrecht AA, Alhan C, Bene MC, la Porta MG, Dräger AM, Feuillard J, Font P, Germing U, Haase D, Homburg CH, et al.,. Standardization of flow cytometry in myelodysplastic syndromes: Report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. Haematologica 2009; 94: 1124-1134.
10. Löffler H, Raststetter J, Haferlach T., Atlas of Clinical Hematology, 6th ed. New York, NY: Springer; 2005.
11. Mufti GJ, Bennett JM, Goasguen J, Bain BJ, Baumann I, Brunning R, Cazzola M, Fenaux P, Germing U, Hellström-Lindberg E, et al.,. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica 2008; 93: 1712-1717.
12. Haferlach C, Rieder H, Lillington DM, Dastugue N, Hagemeijer A, Harbott J, Stilgenbauer S, Knuutila S, Johansson B, Fonatsch C., Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes. Genes Chromosomes Cancer 2007; 46: 494-499.
13. Greenberg P, Cox C, Le Beau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin TJ, Oscier D, et al.,. International Scoring System for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
14. Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, et al.,. Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes. Blood 2012; 120: 2454-2465.
15. Matarraz S, Lopez A, Barrena S, Fernandez C, Jensen E, Flores-Montero J, Rasillo A, Sayagues JM, Sanchez ML, Barcena P, et al.,. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients. Cytometry B Clin Cytom 2010; 78: 154-168.
16. Chu SC, Wang TF, Li CC, Kao RH, Li DK, Su YC, Wells DA, Loken MR., Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes. Leuk Res 2011; 35: 868-873.
17. Aalbers AM, van den Heuvel-Eibrink MM, de Haas V, Te Marvelde JG, de Jong AX, van der Burg M, Dworzak M, Hasle H, Locatelli F, De Moerloose B, et al.,. Leukemia. Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood. Leukemia 2013; 27: 1923-1925.